PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.00%
Negative revenue growth while QRVO stands at 59.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.56%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-0.77%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.89%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
4.76%
Positive net income growth while QRVO is negative. John Neff might see a big relative performance advantage.
3.90%
Positive EPS growth while QRVO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.26%
Positive diluted EPS growth while QRVO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.82%
Share reduction while QRVO is at 0.40%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.77%
Reduced diluted shares while QRVO is at 1.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
11.84%
Dividend growth of 11.84% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
1.49%
Positive OCF growth while QRVO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-0.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
40.82%
10Y revenue/share CAGR above 1.5x QRVO's 0.50%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
4.85%
5Y revenue/share CAGR above 1.5x QRVO's 0.50%. David Dodd would look for consistent product or market expansions fueling outperformance.
17.82%
3Y revenue/share CAGR above 1.5x QRVO's 0.50%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
149.80%
10Y OCF/share CAGR under 50% of QRVO's 488.02%. Michael Burry would worry about a persistent underperformance in cash creation.
34.74%
Below 50% of QRVO's 488.02%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
45.06%
3Y OCF/share CAGR under 50% of QRVO's 488.02%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
102.44%
Net income/share CAGR at 75-90% of QRVO's 118.04%. Bill Ackman would press for strategic moves to boost long-term earnings.
2.85%
Below 50% of QRVO's 118.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
248.52%
3Y net income/share CAGR above 1.5x QRVO's 118.04%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
32.16%
Below 50% of QRVO's 329.10%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.44%
Below 50% of QRVO's 329.10%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-0.13%
Negative 3Y equity/share growth while QRVO is at 329.10%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1175.51%
Dividend/share CAGR of 1175.51% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
192.39%
Dividend/share CAGR of 192.39% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
80.78%
3Y dividend/share CAGR of 80.78% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-21.34%
Firm’s AR is declining while QRVO shows 41.67%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.52%
Inventory is declining while QRVO stands at 104.04%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.87%
Negative asset growth while QRVO invests at 491.31%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.58%
Under 50% of QRVO's 586.58%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.29%
We’re deleveraging while QRVO stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.16%
Our R&D shrinks while QRVO invests at 136.32%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.68%
We cut SG&A while QRVO invests at 384.01%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.